1 | Association of Fluid Balance With Short- and Long-term Respiratory Outcomes in Extremely Premature Neonates: A Secondary Analysis of a Randomized Clinical Trial. (Starr MC, Griffin R, Gist KM, Segar JL, Raina R, Guillet R, Nesargi S, Menon S, Anderson N, Askenazi DJ, Selewski DT, Neonatal Kidney Collaborative Research Committee) JAMA Netw Open 2022 Dec 01;5(12):e2248826 15 Citations |
1 | The benefits of iron supplementation following blood donation vary with baseline iron status. (Mast AE, Szabo A, Stone M, Cable RG, Spencer BR, Kiss JE, NHLBI Recipient Epidemiology Donor Evaluation Study (REDS)-III) Am J Hematol 2020 Jul;95(7):784-791 21 Citations |
1 | Factors associated with shunt-dependent hydrocephalus after decompressive craniectomy for traumatic brain injury. (Vedantam A, Yamal JM, Hwang H, Robertson CS, Gopinath SP) J Neurosurg 2018 May;128(5):1547-1552 59 Citations |
1 | Erythropoietin Stimulates Tumor Growth via EphB4. (Pradeep S, Huang J, Mora EM, Nick AM, Cho MS, Wu SY, Noh K, Pecot CV, Rupaimoole R, Stein MA, Brock S, Wen Y, Xiong C, Gharpure K, Hansen JM, Nagaraja AS, Previs RA, Vivas-Mejia P, Han HD, Hu W, Mangala LS, Zand B, Stagg LJ, Ladbury JE, Ozpolat B, Alpay SN, Nishimura M, Stone RL, Matsuo K, Armaiz-Peña GN, Dalton HJ, Danes C, Goodman B, Rodriguez-Aguayo C, Kruger C, Schneider A, Haghpeykar S, Jaladurgam P, Hung MC, Coleman RL, Liu J, Li C, Urbauer D, Lopez-Berestein G, Jackson DB, Sood AK) Cancer Cell 2015 Nov 09;28(5):610-622 75 Citations |
1 | Erythropoietin protects cardiomyocytes from cell death during hypoxia/reperfusion injury through activation of survival signaling pathways. (Parvin A, Pranap R, Shalini U, Devendran A, Baker JE, Dhanasekaran A) PLoS One 2014;9(9):e107453 28 Citations |
1 | Editorial Comment to Renoprotective effect of erythropoietin in ischemia/reperfusion injury: possible roles of the Akt/endothelial nitric oxide synthase-dependent pathway. (Regner KR) Int J Urol 2012 Mar;19(3):256 |
1 | American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. (Rizzo JD, Brouwers M, Hurley P, Seidenfeld J, Arcasoy MO, Spivak JL, Bennett CL, Bohlius J, Evanchuk D, Goode MJ, Jakubowski AA, Regan DH, Somerfield MR, American Society of Hematology and the American Society of Clinical Oncology Practice Guideline Update Committee) Blood 2010 Nov 18;116(20):4045-59 181 Citations |
1 | American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. (Rizzo JD, Brouwers M, Hurley P, Seidenfeld J, Arcasoy MO, Spivak JL, Bennett CL, Bohlius J, Evanchuk D, Goode MJ, Jakubowski AA, Regan DH, Somerfield MR, American Society of Clinical Oncology, American Society of Hematology) J Clin Oncol 2010 Nov 20;28(33):4996-5010 233 Citations |
1 | Nandrolone decanoate for the treatment of erythropoietin refractory anemia: a case series. (Chawla B, Iqbal FM, Chawla MS) Compr Ther 2009;35(3-4):199-203 5 Citations |
1 | Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update. (Rizzo JD, Somerfield MR, Hagerty KL, Seidenfeld J, Bohlius J, Bennett CL, Cella DF, Djulbegovic B, Goode MJ, Jakubowski AA, Rarick MU, Regan DH, Lichtin AE, American Society of Clinical Oncology, American Society of Hematology) J Clin Oncol 2008 Jan 01;26(1):132-49 262 Citations |
1 | Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update. (Rizzo JD, Somerfield MR, Hagerty KL, Seidenfeld J, Bohlius J, Bennett CL, Cella DF, Djulbegovic B, Goode MJ, Jakubowski AA, Rarick MU, Regan DH, Lichtin AE) Blood 2008 Jan 01;111(1):25-41 145 Citations |
1 | Darbepoetin alfa protects the rat heart against infarction: dose-response, phase of action, and mechanisms. (Baker JE, Kozik D, Hsu AK, Fu X, Tweddell JS, Gross GJ) J Cardiovasc Pharmacol 2007 Jun;49(6):337-45 43 Citations |
1 | Increased erythropoietin elimination in fetal sheep following chronic phlebotomy. (Freise KJ, Widness JA, Segar JL, Schmidt RL, Veng-Pedersen P) Pharm Res 2007 Sep;24(9):1653-9 7 Citations |
1 | Characterization of murine JAK2V617F-positive myeloproliferative disease. (Bumm TG, Elsea C, Corbin AS, Loriaux M, Sherbenou D, Wood L, Deininger J, Silver RT, Druker BJ, Deininger MW) Cancer Res 2006 Dec 01;66(23):11156-65 166 Citations |
1 | Sleeping Beauty-mediated transposition and long-term expression in vivo: use of the LoxP/Cre recombinase system to distinguish transposition-specific expression. (Score PR, Belur LR, Frandsen JL, Geurts JL, Yamaguchi T, Somia NV, Hackett PB, Largaespada DA, McIvor RS) Mol Ther 2006 Mar;13(3):617-24 27 Citations |
1 | Specific pharmacological dimerization of KDR in lentivirally transduced human hematopoietic cells activates anti-apoptotic and proliferative mechanisms. (Siatskas C, Underwood J, Ramezani A, Hawley RG, Medin JA) FASEB J 2005 Oct;19(12):1752-4 10 Citations |
1 | Erythropoietin mimics ischemic preconditioning. (Baker JE) Vascul Pharmacol 2005;42(5-6):233-41 66 Citations |
1 | Evidence-based medicine: can it be applied to stimulation of erythropoiesis for patients with malignancy? (Rizzo JD) Best Pract Res Clin Haematol 2005;18(3):439-48 2 Citations |
2 | Erythropoietin protects the infant heart against ischemia-reperfusion injury by triggering multiple signaling pathways. (Rafiee P, Shi Y, Su J, Pritchard KA Jr, Tweddell JS, Baker JE) Basic Res Cardiol 2005 May;100(3):187-97 98 Citations |
1 | Subnormal rise of erythropoietin in patients receiving interferon and ribavirin combination therapy for hepatitis C. (Trivedi HS, Trivedi M) J Clin Gastroenterol 2004 Aug;38(7):595-8 14 Citations |
2 | Acute cardioprotective effects of erythropoietin in infant rabbits are mediated by activation of protein kinases and potassium channels. (Shi Y, Rafiee P, Su J, Pritchard KA Jr, Tweddell JS, Baker JE) Basic Res Cardiol 2004 May;99(3):173-82 80 Citations |
1 | Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. (Rizzo JD, Lichtin AE, Woolf SH, Seidenfeld J, Bennett CL, Cella D, Djulbegovic B, Goode MJ, Jakubowski AA, Lee SJ, Miller CB, Rarick MU, Regan DH, Browman GP, Gordon MS, American Society of Clinical Oncology. American Society of Hematology) J Clin Oncol 2002 Oct 01;20(19):4083-107 402 Citations |
1 | Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. (Rizzo JD, Lichtin AE, Woolf SH, Seidenfeld J, Bennett CL, Cella D, Djulbegovic B, Goode MJ, Jakubowski AA, Lee SJ, Miller CB, Rarick MU, Regan DH, Browman GP, Gordon MS, American Society of Clinical Oncology, Americcan Society of Hematology) Blood 2002 Oct 01;100(7):2303-20 204 Citations |
1 | Erythropoietin: a paradigm for the development of practice guidelines. (Rizzo JD, Seidenfeld J, Piper M, Aronson N, Lichtin A, Littlewood TJ) Hematology Am Soc Hematol Educ Program 2001:10-30 35 Citations |
1 | Pilot study of low-dose interleukin-11 in patients with bone marrow failure. (Kurzrock R, Cortes J, Thomas DA, Jeha S, Pilat S, Talpaz M) J Clin Oncol 2001 Nov 01;19(21):4165-72 61 Citations |
1 | Expansion of megakaryocyte precursors and stem cells from umbilical cord blood CD34+ cells in collagen and liquid culture media. (Shaw PH, Olszewski M, Kletzel M) J Hematother Stem Cell Res 2001 Jun;10(3):391-403 11 Citations |
1 | Intravenous iron dextran and erythropoietin use in pediatric hemodialysis patients. (Greenbaum LA, Pan CG, Caley C, Nelson T, Sheth KJ) Pediatr Nephrol 2000 Sep;14(10-11):908-11 19 Citations |
1 | Safety and efficacy of erythropoietin in children with chronic renal failure. (Brandt JR, Avner ED, Hickman RO, Watkins SL) Pediatr Nephrol 1999 Feb;13(2):143-7 52 Citations |
1 | Erythropoietin response to anaemia is not altered by surgery or recombinant human erythropoietin therapy. (Goodnough LT, Price TH, Parvin CA, Friedman KD, Vogler WR, Khan N, Sacher R, Johnston M, Wissel M, Ciavarella D) Br J Haematol 1994 Aug;87(4):695-9 35 Citations |
1 | A phase III trial of recombinant human erythropoietin therapy in nonanemic orthopedic patients subjected to aggressive removal of blood for autologous use: dose, response, toxicity, and efficacy. (Goodnough LT, Price TH, Friedman KD, Johnston M, Ciavarella D, Khan N, Sacher R, Vogler WR, Wissel M, Abels RI) Transfusion 1994 Jan;34(1):66-71 117 Citations |
1 | Suppression of chronic myelogenous leukemia colony growth by interleukin-4. (Estrov Z, Markowitz AB, Kurzrock R, Wetzler M, Kantarjian HM, Ferrajoli A, Gutterman JU, Talpaz M) Leukemia 1993 Feb;7(2):214-20 18 Citations |
1 | Very low doses of GM-CSF administered alone or with erythropoietin in aplastic anemia. (Kurzrock R, Talpaz M, Gutterman JU) Am J Med 1992 Jul;93(1):41-8 29 Citations |
1 | Erythropoietin treatment in patients with myelodysplastic syndrome and anemia. (Kurzrock R, Talpaz M, Estey E, O'Brien S, Estrov Z, Gutterman JU) Leukemia 1991 Nov;5(11):985-90 44 Citations |
1 | Biological molecules in the treatment of hematological disorders. (Kurzrock R, Talpaz M, Gutterman U) Sangre (Barc) 1989 Feb;34(1):53-8 |
1 | Chromatography of human urinary erythropoietin and granulocyte colony-stimulating factor on insolubilized phytohaemagglutinin. (Sieber F) Biochim Biophys Acta 1977 Jan 24;496(1):146-54 3 Citations |
1 | Erythroid progenitors in mouse bone marrow detected by macroscopic colony formation in culture. (Iscove NN, Sieber F) Exp Hematol 1975 Jan;3(1):32-43 317 Citations |
1 | Erythroid colony formation in cultures of mouse and human bone marrow: analysis of the requirement for erythropoietin by gel filtration and affinity chromatography on agarose-concanavalin A. (Iscove NN, Sieber F, Winterhalter KH) J Cell Physiol 1974 Apr;83(2):309-20 670 Citations |